Advance Search
WANG Zailing, LIU Jiangdong, ZHANG Xiaojun, LIU Xiangke. Effect of Bifid Triple Viable Bacteria and its influence on intestinal flora in patients with liver cirrhosis[J]. Journal of Clinical Medicine in Practice, 2019, 23(20): 39-41. DOI: 10.7619/jcmp.201920011
Citation: WANG Zailing, LIU Jiangdong, ZHANG Xiaojun, LIU Xiangke. Effect of Bifid Triple Viable Bacteria and its influence on intestinal flora in patients with liver cirrhosis[J]. Journal of Clinical Medicine in Practice, 2019, 23(20): 39-41. DOI: 10.7619/jcmp.201920011
shu

Effect of Bifid Triple Viable Bacteria and its influence on intestinal flora in patients with liver cirrhosis

  • 1.

    Department of Gastroenterology, Baishi Hua Changqing Staff Hospital, Xi′an, Shaanxi, 710201

  • 2.

    Department of General Surgery, Baishi Hua Changqing Staff Hospital, Xi′an, Shaanxi, 710201

  • 3.

    Endoscopy Center, Baishi Hua Changqing Staff Hospital, Xi′an, Shaanxi, 710201

More Information
  • Received Date: August 16, 2019
  • Accepted Date: September 21, 2019
  • Available Online: February 28, 2021
  • Published Date: October 27, 2019
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the effect of Bifid Triple Viable Bacteria and its influence on intestinal flora in patients with liver cirrhosis.
      Methods  A total of 116 patients with liver cirrhosis in our hospital were selected and were divided into two groups. The control group (n=58) was given routine comprehensive treatment, and the study group (n=58) was additionally given Bifid Triple Viable Bacteria therapy. The changes of intestinal flora, and efficacy of liver cirrhosis were analyzed.
      Results  The overall effective rate of liver cirrhosis in the study group was higher than that in the control group (P < 0.05). After treatment, the levels of aerobic and anaerobic bacteria in the study group were higher and yeast-like fungi level was lower than that in the control group (P < 0.05).
      Conclusion  Bifid Triple Viable Bacteria can optimize special treatment efficacy of liver cirrhosis and correct intestinal flora disorder.
    • FullText(HTML)
    • References (18)
  • [1]
    史保生. 双歧杆菌乳杆菌三联活菌片对非酒精性脂肪性肝病的改善作用[J]. 中国慢性病预防与控制, 2017, 25(5): 387-390. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXB201705022.htm
    [2]
    程康文, 左伯海, 王贵和, 等. 双歧杆菌三联活菌胶囊对进展期胃癌术后化疗患者化疗副作用及肠道菌群的影响[J]. 中国微生态学杂志, 2018, 30(6): 667-672. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWS201806011.htm
    [3]
    王桂玲, 王艳萍, 努尔比耶. 双歧杆菌三联活菌联合膳食纤维素治疗维吾尔族肥胖症合并脂肪肝疗效观察[J]. 中国慢性病预防与控制, 2018, 26(4): 311-314. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXB201804017.htm
    [4]
    杨文伟. 马来酸曲美布汀联合双歧三联活菌胶囊对糖尿病性腹泻患者肠道菌群的影响及疗效观察[J]. 中国微生态学杂志, 2017, 29(2): 192-195. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWS201702020.htm
    [5]
    苏子云, 袁叶, 彭怡, 等. 肠道菌群对硫酸氢氯吡格雷及其活性代谢产物在大鼠体内药动学的影响[J]. 中国医院药学杂志, 2017, 37(21): 2113-2116. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYZ201721003.htm
    [6]
    王玲玲, 吴金明, 黄美君. 曲美布汀联合双歧杆菌三联活菌胶囊对功能性消化不良重叠IBS-D患者肠道的影响[J]. 中国微生态学杂志, 2018, 30(1): 59-62. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWS201801015.htm
    [7]
    杨艳君. 儿童迁延性腹泻患者肠道菌群和肠黏膜屏障功能的变化以及双歧杆菌三联活菌散的干预作用[J]. 中国微生态学杂志, 2018, 30(6): 700-702, 705. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWS201806019.htm
    [8]
    郑宏斌. 三联活菌胶囊联合抗生素治疗对自发性细菌性腹膜炎患者炎性因子、肠粘膜屏障功能的影响[J]. 海南医学院学报, 2018, 24(12): 1151-1154. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYY201812004.htm
    [9]
    朱晓红, 王全楚, 董晓锋, 等. 蒙脱石散、双歧杆菌三联活菌联合参苓白术散治疗酒精性肝病的临床观察[J]. 中西医结合肝病杂志, 2018, 28(3): 178-180. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXGB201803019.htm
    [10]
    王丽, 黄娟, 冷红春. 秋泻灵联合双歧杆菌三联活菌制剂对小儿轮状病毒性肠炎免疫系统及微炎症状态的影响[J]. 中国妇幼保健, 2017, 32(17): 4140-4143. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201717041.htm
    [11]
    朱剑南. 胆囊切除术后腹泻患者应用双歧三联活菌胶囊改善其肠道微生态紊乱的效果评价[J]. 中国微生态学杂志, 2017, 29(5): 567-569, 580. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWS201705018.htm
    [12]
    刘丰. 双歧三联活菌胶囊对结肠造口术后腹泻患者肠道菌群及肠黏膜屏障功能的影响[J]. 中国微生态学杂志, 2017, 29(7): 814-817. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWS201707017.htm
    [13]
    张帆. 双歧三联活菌胶囊联合甘草泻心汤对溃疡性结肠炎患者肠道菌群和肠黏膜屏障的影响[J]. 中国中西医结合消化杂志, 2017, 25(9): 690-693. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXPW201709017.htm
    [14]
    钱见楚, 吴一鸣. 门冬氨酸鸟氨酸联合双歧三联活菌胶囊对亚临床肝性脑病患者内毒素血症及肠道微生态的影响[J]. 中国微生态学杂志, 2017, 29(6): 700-703. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWS201706022.htm
    [15]
    段少琼, 周天彤, 刘丽, 等. 双歧杆菌三联活菌胶囊治疗慢性乙型肝炎合并肝硬化疗效及对肝功能、肝纤维化的影响[J]. 疑难病杂志, 2018, 17(4): 362-365. https://www.cnki.com.cn/Article/CJFDTOTAL-YNBZ201804013.htm
    [16]
    李波, 邓存良. 恩替卡韦联合双歧杆菌乳杆菌三联活菌片治疗失代偿期乙型肝炎肝硬化临床疗效观察[J]. 实用肝脏病杂志, 2018, 21(5): 669-672. https://www.cnki.com.cn/Article/CJFDTOTAL-GBSY201805004.htm
    [17]
    吕金兰. 常乐康对乙肝肝硬化患者肠道菌群和肠道黏膜屏障功能的影响[J]. 中国微生态学杂志, 2017, 29(8): 913-915. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWS201708011.htm
    [18]
    刘礼剑, 杨成宁, 沈飞霞, 等. 基于"肠-肝轴"肠道菌群调节观察当归芍药散加味治疗肝硬化的临床疗效[J]. 世界中医药, 2017, 12(8): 1789-1792. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZA201708016.htm
    • Related Articles

  • Cited by

    Periodical cited type(2)

    1. 屈文燕，胡迪，许海阳，林荣海. 酪酸梭菌肠球菌三联活菌对危重症患者肠道功能的影响. 中国现代医生. 2022(16): 89-92 .
    2. 张千，洪锋. 双歧三联活菌与乳果糖治疗肝硬化肠源性内毒素血症的疗效. 中国继续医学教育. 2021(35): 153-157 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (253) PDF downloads (5) Cited by(3)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return